HDAC2 and acute myeloid leukemia: These results are consistent with our previous findings using panobinostat [14], suggesting that HDAC1, HDAC2, and HDAC3 participate in the regulation of BRCA1, CHK1, and RAD51 expression and play important roles in the antileukemic activities of ara-C or DNR in AML cells.